Based on the percentage of PATZ1 positive cells, we divided our cohort of tumor samples in three groups, namely Low (absent or <20%), Medium (>20%; <70%), and High (≥70%) PATZ1 (Table 4). Here, PATZ1 is linked to neoplasm.